or Try an Advanced Search...

    Immune Response Stocks List

    Symbol Grade Name % Change
    ANIX D Anixa Biosciences, Inc. 4.58
    ZTS D Zoetis Inc. 0.14
    CVM F Cel-Sci Corporation -1.44
    RAPT F RAPT Therapeutics, Inc. 2.86
    ACET F Adicet Bio, Inc. -1.53
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Cancer Biotechnology Disease Immune System Medicine Antigen Chimeric Antigen Receptor Clinical Medicine Immunology Adoptive Cell Transfer Allergies Amines Animal Health Anti Infectives Antibodies Autoimmunity Biopharmaceutical Blood Test Cancer Immunotherapy Cancer Treatment

    Related ETFs - A few ETFs which own one or more of the above listed Immune Response stocks.

    Symbol Grade Name Weight
    PAWZ D ProShares Pet Care ETF 10.1
    MOO D Market Vectors Agribusiness ETF 7.5
    PINK D Simplify Health Care ETF 4.86
    PPH D Market Vectors Pharmaceutical ETF 4.68
    VNSE A Natixis Vaughan Nelson Select ETF 4.34
    View all Immune Response ETFs...
    Compare ETFs
    Compare MOO to PINK Compare PAWZ to PPH Compare PINK to PPH

        Immune Response Stocks Recent News

        Date Stock Title
        Nov 22 ANIX Anixa rises as board approves Bitcoin as a treasury reserve asset
        Nov 22 ANIX Anixa Biosciences board approves purchase of Bitcoin as treasury reserve asset
        Nov 20 ZTS Zoetis Inc. (ZTS) Management presents at Jefferies London Healthcare Conference (Transcript)
        Nov 19 ZTS Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference
        Nov 19 ZTS Is Zoetis Inc. (NYSE:ZTS) Trading At A 29% Discount?
        Nov 18 ACET Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
        Nov 18 ZTS SDZNY vs. ZTS: Which Stock Should Value Investors Buy Now?
        Nov 18 ANIX Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
        Nov 18 ACET Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
        Nov 18 ACET Is Adicet Bio (NASDAQ:ACET) In A Good Position To Deliver On Growth Plans?
        Nov 18 ZTS Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Cancer Biotechnology Disease Immune System Medicine Antigen Chimeric Antigen Receptor Clinical Medicine Immunology Adoptive Cell Transfer Allergies Amines Animal Health Anti Infectives Antibodies Autoimmunity Biopharmaceutical Blood Test Cancer Immunotherapy Cancer Treatment
        Immune Response

        Immune response is the body's natural defense against foreign substances, such as bacteria, viruses, and toxins. It is a complex process involving the recognition of foreign substances, the production of antibodies to fight them, and the destruction of the foreign substances. The immune system is made up of a network of cells, tissues, and organs that work together to protect the body from disease.

        Browse All Tags